Document is current

Article History

Received: 2 June 2024

Accepted: 7 August 2024

First Online: 21 August 2024

Declarations

:

: MPN declares speaker fees by AstraZeneca, Imedos Systems, and Vifor Pharma, advisory board compensation from Boehringer Ingelheim and grant support by Amgen, unrelated to this article. The research and educational grants do not impact on his personal remuneration. JB reports speaker fees from IMEDOS and travel grant from Servier. MJW declares speaking honoraria from Berlin Heart and ZOLL, not related to this article. FR has not received personal payments from pharmaceutical companies or device manufacturers in the last 3 years (remuneration for the time spent in activities, such as participation as steering committee member of clinical trials and member of the Pfizer Research Award selection committee in Switzerland, was made directly to the University of Zurich). The Department of Cardiology (University Hospital of Zurich/University of Zurich) reports research-, educational- and/or travel grants from Abbott, Amgen, Astra Zeneca, Bayer, Berlin Heart, B. Braun, Biosense Webster, Biosensors Europe AG, Biotronik, BMS, Boehringer Ingelheim, Boston Scientific, Bracco, Cardinal Health Switzerland, Corteria, Daiichi, Diatools AG, Edwards Lifesciences, Guidant Europe NV (BS), Hamilton Health Sciences, Kaneka Corporation, Kantar, Labormedizinisches Zentrum, Medtronic, MSD, Mundipharma Medical Company, Novartis, Novo Nordisk, Orion, Pfizer, Quintiles Switzerland Sarl, Roche Diagnostics, Sahajanand IN, Sanofi, Sarstedt AG, Servier, SIS Medical, SSS International Clinical Research, Terumo Deutschland, Trama Solutions, V-Wave, Vascular Medical, Vifor, Wissens Plus, and ZOLL. IS declares in the last 10 years and until 2022 consulting fees, travel grant, and honoraria from Amgen, Astra Zeneca, Daiichi Sankio, Medtronic, MSD, Novartis, Recordati, Sanofi, and Servier unrelated to the topic of the paper. AJF declares grant support from Berlin Heart, related to this article as well as fees from Alnylam, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Fresenius, Imedos Systems, Medtronic, MSD, Mundipharma, Novartis, Pierre Fabre, Pfizer, Roche, Schwabe Pharma, Vifor, and Zoll, as well as grant support by Novartis and AstraZeneca unrelated to this article. All other authors have no conflict of interest related to the paper’s topic.